FFEFX
Price
$14.50
Change
+$0.01 (+0.07%)
Updated
Jun 5 closing price
Net Assets
3.01B
RMEBX
Price
$57.64
Change
-$0.04 (-0.07%)
Updated
Jun 5 closing price
Net Assets
105.31B
Interact to see
Advertisement

FFEFX vs RMEBX

Header iconFFEFX vs RMEBX Comparison
Open Charts FFEFX vs RMEBXBanner chart's image
Nuveen Dividend Value R6
Price$14.50
Change+$0.01 (+0.07%)
VolumeN/A
Net Assets3.01B
American Funds American Mutual R2E
Price$57.64
Change-$0.04 (-0.07%)
VolumeN/A
Net Assets105.31B
FFEFX vs RMEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FFEFX vs. RMEBX commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FFEFX is a Buy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 105B vs. FFEFX (3.02B). FFEFX pays higher dividends than RMEBX: FFEFX (1.54) vs RMEBX (1.16). FFEFX was incepted earlier than RMEBX: FFEFX (12 years) vs RMEBX (11 years). RMEBX (1.07) is less costly to investors than FFEFX (0.64). FFEFX is a more actively managed with annual turnover of: 79.00 vs. RMEBX (31.00). RMEBX has a lower initial minimum investment than FFEFX: RMEBX (250) vs FFEFX (1000000). RMEBX annual gain was more profitable for investors over the last year : 8.30 vs. FFEFX (-3.95). RMEBX return over 5 years is better than : 49.85 vs. FFEFX (27.51).
FFEFXRMEBXFFEFX / RMEBX
Total Expense Ratio0.611.0757%
Annual Report Gross Expense Ratio0.641.0760%
Fund Existence12 years11 years-
Gain YTD0.7665.34914%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets3.02B105B3%
Annual Yield % from dividends1.541.16133%
Returns for 1 year-3.958.30-48%
Returns for 3 years3.5217.9620%
Returns for 5 years27.5149.8555%
Returns for 10 years-1.0368.21-2%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERV5.720.43
+8.22%
Verve Therapeutics
VRNT18.780.97
+5.45%
Verint Systems
CHRS0.80N/A
+0.48%
Coherus Oncology Inc
CHSCN25.15-0.05
-0.20%
CHS
PRI265.13-2.99
-1.12%
PRIMERICA